Could Digital Twins Forecast Forensic Risk?

• by Kathryn Wighton

• May 18, 2026

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

• by Kathryn Wighton

• July 14, 2026

• 2 min

Folate Biomarkers Linked to Lung Cancer

Cross-sectional NHANES analysis found associations between select folate markers and self-reported physician-diagnosed lung cancer, though the direction and clinical significance of the relationship remain unclear

• by Andrea Surnit

• May 11, 2026

• 3 min

FDA Expands Gene Therapy for Younger Patients

Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

• by Kathryn Wighton

• July 2, 2026

• 3 min